01 December 2005
Med Sci Monit 2005; 11(12): CR562-569 :: ID: 438852
Background: Diabetes is associated with reduced tolerance to heat. Theinsulin sensitizer rosiglitazone (RSG), administered for glycemic control, has a secondary effect inincreasing vascular endothelial function. The hypothesis to be tested was if administration of rosiglitazonewould increase heat tolerance in people with diabetes. Material/Methods: Thirty subjects with diabetesand thirty control subjects were examined. A subset of 21 subjects with diabetes had RSG administeredat 4 mg per day for a period of 1 year. At 2 weeks, 4 weeks, 3 months, 6 months, and 1 year post administration,measurements were taken to assess any potential impact of this drug on thermoregulation. Parameters measuredwere sweat rate, skin temperature, body core temperature, and skin blood flow. Results: Results of theseexperiments showed that subjects with diabetes at baseline had 1) sensory impairment, 2) sweat glandimpairment 3) high skin temperatures, 4) and low blood flow reduction during heat exposure, all leadingto higher core temperature compared to controls subjects. After administration of rosiglitazone for 1year significant improvements in thermoregulation were observed. Trends for improvement in thermoregulationwere observed close to that of age matched control subjects. Conclusions: Heat tolerance can be improvedin people with diabetes when taking the insulin sensitizer RSG for Glycemic control, probably due toincreased endothelial cell function.
Keywords: Body Temperature Regulation - drug effects, Diabetes Mellitus, Type 2 - physiopathology, Hot Temperature, Hypoglycemic Agents - pharmacology, Skin Temperature - drug effects, Thiazolidinediones - pharmacology
01 July 2022 : EditorialEditorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2
Med Sci Monit 2022; 28:e937676
27 June 2022 : Clinical ResearchShoulder Injury Related to Vaccine Administration (SIRVA) in 16 Patients Following COVID-19 Vaccination Who...
Med Sci Monit In Press; DOI: 10.12659/MSM.937430
04 June 2022 : Clinical ResearchScreening for SARS-CoV-2 Infection in Students at the Medical University of Warsaw, Poland Between November...
Med Sci Monit 2022; 28:e936962
30 May 2022 : Clinical ResearchEffects of Wearing Face Masks on Exercise Capacity and Ventilatory Anaerobic Threshold in Healthy Subjects ...
Med Sci Monit 2022; 28:e936069
01 Jul 2022 : Clinical ResearchDoes Early-Period Patient Dissatisfaction Turn Into Satisfaction Over Time After Total Knee Replacement?
Med Sci Monit In Press; DOI: 10.12659/MSM.936792
30 Jun 2022 : Laboratory ResearchBcl-2 19-kDa Interacting Protein 3 (BNIP3)-Mediated Mitophagy Attenuates Intermittent Hypoxia-Induced Human...
Med Sci Monit In Press; DOI: 10.12659/MSM.936760
30 Jun 2022 : Clinical ResearchAntioxidant System and Ions Concentrations After Femoral Neck and Resurfacing Hip Arthroplasty
Med Sci Monit In Press; DOI: 10.12659/MSM.936335
Most Viewed Current Articles
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Nov 2020 : Review articleLong-Term Respiratory and Neurological Sequelae of COVID-19
Med Sci Monit 2020; 26:e928996